Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (231) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Corporate presentations (26) Apply Corporate presentations filter
- Pipeline (26) Apply Pipeline filter
- Shareholder meeting (24) Apply Shareholder meeting filter
- Team member (22) Apply Team member filter
- Videos (16) Apply Videos filter
- Financial reports (12) Apply Financial reports filter
- Webcasts and audio (12) Apply Webcasts and audio filter
- Analyst (11) Apply Analyst filter
- Investor contact (6) Apply Investor contact filter
- Event (4) Apply Event filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
Company Secretary and Registered Office
Oxford Biomedica plc
Windrush Court
Transport Way
Oxford
OX4 6LT
United Kingdom
Tel: +44 (0) 1865 783 000
Corporate brokers
James Steel
Christopher Golden
Tel: +44 (0)20 7418 8900
Financial and Corporate Communications
85 Gresham Street
London
EC2V 7NQ
Tel: +44 (0)20 3709 5700
Oxford BioMedica Announces a Strategic Alliance with Orchard Therapeutics
Oxford, UK & London, UK– 29 November 2016: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE: OXB), a leading gene
Block Listing Return
RNS Number : 1753T
Oxford Biomedica PLC
03 January 2017